Publications

Cancer Immunotherapy Based on Mutation-Specific CD4+ T Cells in a Patient with Epithelial Cancer

Eric Tran, Simon Turcotte, Alena Gros, Paul F. Robbins, Yong-Chen Lu, Mark E. Dudley... plus more

View Publication +

Immune recognition of somatic mutations leading to complete durable regression in metastatic breast cancer

Nikolaos Zacharakis, Harshini Chinnasamy, Mary Black, Hui Xu, Yong-Chen Lu, Zhili Zheng... plus more

View Publication +

T-Cell Transfer Therapy Targeting Mutant KRAS in Cancer

Eric Tran, Ph.D., Paul F. Robbins, Ph.D., Yong-Chen Lu, Ph.D., Todd D. Prickett, Ph.D.... plus more

View Publication +

Mining exomic sequencing data to identify mutated antigens recognised by adoptively transferred tumor-reactive T cells

Paul F Robbins, Yong-Chen Lu, Mona El-Gamil, Yong F Li, Colin Gross, Jared Gartner, Jimmy C Lin, Jamie K Teer... plus more

View Publication +

T cell therapies to viral antigens

Emily Blyth, Leighton Clancy, Renee Simms, Chun K. K. Ma, Jane Burgess... plus more

View Publication +

Adoptive cellular therapy for cytomegalovirus infection following allogeneic stem cell transplantation using virus-specific T cells

Stephen Mackinnon, Kirsty Thomson, Stephanie Verfuerth, Karl Peggs, Mark Lowdell

View Publication +

Clonal neoantigens elicit T cell immunoreactivity and sensitivity to immune checkpoint blockad

Nicholas McGranahan et al

View Publication +

Adoptive cell therapy with tumour-infiltrating lymphocytes: the emerging importance of clonal neoantigen targets for next-generation products in non-small cell lung cancer

Jane Robertson, Max Salm, Markus Dangl

View Publication +

Neoantigen-directed immune escape in lung cancer evolution

Rachel Rosenthal et al.

View Publication +

Differential binding affinity of mutated peptides for MHC class I is a predictor of survival in advanced lung cancer and melanoma.

Ghorani E, Rosenthal R, McGranahan N, Reading JL, Lynch M, Peggs KS, Swanton C, Quezada SA. Ann Oncol.

View Publication +

Allele-specific HLA loss and immune escape in lung cancer evolution

Nicholas McGranahan et al

View Publication +

Insertion-and-deletion-derived tumour-specific neoantigens and the immunogenic phenotype: a pan-cancer analysis

Samra Turajlic et al

View Publication +

The “Achilles' heel” of cancer and its implications for the development of novel immunotherapeutic strategies

Kroopa Joshi et al

View Publication +

Phylogenetic ctDNA analysis depicts early-stage lung cancer evolution

Christopher Abbosh et al

View Publication +

Detection of ubiquitous and heterogeneous mutations in cell-free DNA from patients with early-stage non-small-cell lung cancer

Mariam Jamal-Hanjani et al

View Publication +

Tracking the Evolution of Non-Small-Cell Lung Cancer

Mariam Jamal-Hanjani et al

View Publication +

The function and dysfunction of memory CD8+ T cells in tumor immunity.

Reading JL, Galvez-Cancino F, Swanton C, Lladser A, Peggs KS, Quezada SA.

View Publication +

Disclaimer of liability

The material and information contained on this website is for general information purposes only. Whilst we endeavour to keep the information up to date and correct, Achilles Therapeutics Limited and its affiliates (together "Achilles") make no representations or warranties of any kind, express or implied about the completeness, accuracy, reliability, suitability or availability with respect to the website or the information, products, services or related graphics contained on the website for any purpose. Any reliance you place on such material is therefore strictly at your own risk.

Certain links in this website will lead to websites which are not under the control of Achilles. When you activate these you will leave the Achilles website. Achilles has no control over and accepts no liability in respect of materials, products or services available on any website which is not under the control of Achilles.

To the extent not prohibited by law, in no circumstances shall Achilles be liable to you or any other third parties for any loss or damage (including, without limitation, damage for loss of business or loss of profits) arising directly or indirectly from your use of, or inability to use, this site or any of the material contained in it.

These disclaimers and exclusions shall be governed by and construed in accordance with English law.